Abstract:NGS-based genetic testing in the diagnosis of rare diseases holds great promise to serve as a first-tier genetic testing tool in the near future.Advancement of NGS technologies provides many options for diagnosing rare disorders associated with different types of genetic variants. Factors must be balanced in a ‘fit-for-purpose’ implementation.The accuracy and reproducibility of NGS should be evaluated in a clinical setting to deliver reliable genetic testing results in different clinical stages of rare diseases.Artificial intelligence (AI) will play a central role in integrating diverse diagnosis information toward an enhanced diagnosis power for rare diseases. Next-generation sequencing (NGS) technologies have changed the landscape of genetic testing in rare diseases. However, the rapid evolution of NGS technologies has outpaced its clinical adoption. Here, we re-evaluate the critical steps in the clinical application of NGS-based genetic testing from an informatics perspective. We suggest a ‘fit-for-purpose’ triage of current NGS technologies. We also point out potential shortcomings in the clinical management of genetic variants and offer ideas for potential improvement. We specifically emphasize the importance of ensuring the accuracy and reproducibility of NGS-based genetic testing in the context of rare disease diagnosis. We highlight the role of artificial intelligence (AI) in enhancing understanding and prioritization of variance in the clinical setting and propose deep learning frameworks for further investigation. Next-generation sequencing (NGS) technologies have changed the landscape of genetic testing in rare diseases. However, the rapid evolution of NGS technologies has outpaced its clinical adoption. Here, we re-evaluate the critical steps in the clinical application of NGS-based genetic testing from an informatics perspective. We suggest a ‘fit-for-purpose’ triage of current NGS technologies. We also point out potential shortcomings in the clinical management of genetic variants and offer ideas for potential improvement. We specifically emphasize the importance of ensuring the accuracy and reproducibility of NGS-based genetic testing in the context of rare disease diagnosis. We highlight the role of artificial intelligence (AI) in enhancing understanding and prioritization of variance in the clinical setting and propose deep learning frameworks for further investigation.

Next-generation sequencing and bioinformatics in rare movement disorders

Application of Next Generation Sequencing Technology in Mendelian Movement Disorders

Bioinformatics of germline variant discovery for rare disease diagnostics: current approaches and remaining challenges

Molecular diagnostic approach to rare neurological diseases from a clinician viewpoint

The expanding diagnostic toolbox for rare genetic diseases

Identification Of Sequence Variants In Genetic Disease-Causing Genes Using Targeted Next-Generation Sequencing

Using Next-Generation Sequencing As A Genetic Diagnostic Tool in Rare Autosomal Recessive Neurologic Mendelian Disorders

Evaluation of an Automated Genome Interpretation Model for Rare Disease Routinely Used in a Clinical Genetic Lab

Toward Clinical Implementation of Next-Generation Sequencing-Based Genetic Testing in Rare Diseases: Where Are We?

Diagnostic and Clinical Utility of Whole Genome Sequencing in a Cohort of Undiagnosed Chinese Families with Rare Diseases

Beyond the exome: what's next in diagnostic testing for Mendelian conditions

Evaluation of an Automated Genome Interpretation Model for Rare Disease Routinely Used in a Clinical Genetic Laboratory.

Solving the molecular diagnostic testing conundrum for Mendelian disorders in the era of next-generation sequencing: single-gene, gene panel, or exome/genome sequencing

Big data and innovative bioinformatics approaches in personalized genomic medicine

New Developments and Possibilities in Reanalysis and Reinterpretation of Whole Exome Sequencing Datasets for Unsolved Rare Diseases Using Machine Learning Approaches

Application of next-generation sequencing technologies in Neurology.

Expanding the Boundaries of RNA Sequencing as a Diagnostic Tool for Rare Mendelian Disease

Insights into Pathogenesis, Techniques for Variant Identification, and Therapeutic Approaches

Rare and undiagnosed diseases: From disease-causing gene identification to mechanism elucidation

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Clinical exome sequencing in the diagnosis of pediatric neuromuscular disease